BOEHRINGER INGELHEIM PTE LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Award: Boehringer Ingelheim is Global Top Employer 2022 2022-01-20 08:00
Award: Boehringer Ingelheim is Global Top Employer 2022 2022-01-20 08:00
Award: Boehringer Ingelheim is Global Top Employer 2022 2022-01-20 08:00
Award: Boehringer Ingelheim is Global Top Employer 2022 2022-01-20 08:00
Award: Boehringer Ingelheim is Global Top Employer 2022 2022-01-20 08:00
Award: Boehringer Ingelheim is Global Top Employer 2022 2022-01-20 08:00
Award: Boehringer Ingelheim is Global Top Employer 2022 2022-01-20 08:00
Financial year 2018: Boehringer Ingelheim grows and invests 2019-04-17 16:30
American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes and established cardiovascular disease in new Expert Consensus Decision Pathway 2018-11-27 15:00
Boehringer Ingelheim achieves modest growth in the first half of 2018 2018-08-01 16:00
Boehringer Ingelheim has a very successful 2017 financial year 2018-04-25 16:41
1